| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2008 | WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety |
| 12/11/2008 | WO2008109110A3 System for regulating blood pressure |
| 12/11/2008 | WO2008106131A3 Combination therapy for treatment of immune disorders |
| 12/11/2008 | WO2008103693A3 Chemical linkers with single amino acids and conjugates thereof |
| 12/11/2008 | WO2008102075A3 Novel therapeutic use for treating leukaemia |
| 12/11/2008 | WO2008100621A3 Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s |
| 12/11/2008 | WO2008099083A3 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases |
| 12/11/2008 | WO2008098143A3 Antimicrobial compounds and methods of use |
| 12/11/2008 | WO2008098077A3 Substituted alkine derivatives as anti-cancer agents |
| 12/11/2008 | WO2008097439A3 Anti-autoimmune antibodies for treatment of pemphigus |
| 12/11/2008 | WO2008095096A3 Let-7 microrna and mimetics thereof as therapeutics for cancer |
| 12/11/2008 | WO2008094937A3 Methods of modulating angiogenesis |
| 12/11/2008 | WO2008094689A3 Potentiation of stem cell homing and treatment of organ dysfunction or organ failure |
| 12/11/2008 | WO2008094254A3 Methods and compositions for the treatment of cancer or other diseases |
| 12/11/2008 | WO2008093302A3 Method for decreasing inflammation and oxidative stress in mammals |
| 12/11/2008 | WO2008087458A3 NEW SIGMA(σ)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION |
| 12/11/2008 | WO2008085074A3 1, 3-dihydroimidazoles for treating cardiovascular disorders |
| 12/11/2008 | WO2008082321A8 Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
| 12/11/2008 | WO2008082009A3 Fused substituted aminopyrrolidine derivative |
| 12/11/2008 | WO2008074108A3 Controlled release pharmaceutical composition of anti-hyperglycemic agent and its preparation |
| 12/11/2008 | WO2008073451A8 Benzoimidazole derivatives as sirtuin (sir) modulating compounds |
| 12/11/2008 | WO2008073138A3 Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors |
| 12/11/2008 | WO2008070940A8 Process of obtainment of soy isoflavones |
| 12/11/2008 | WO2008070823A3 Substrate-mimetic akt inhibitor |
| 12/11/2008 | WO2008070368A3 Methods and compositions for skin care |
| 12/11/2008 | WO2008066626A3 METHODS FOR THE TREATMENT OF Aβ RELATED DISORDERS AND COMPOSITIONS THEREFOR |
| 12/11/2008 | WO2008063671A3 Heterobicyclic metalloprotease inhibitors |
| 12/11/2008 | WO2008063603A3 Methods, compositions, and kits for treating pain and pruritis |
| 12/11/2008 | WO2008048636A3 Small molecule intervention for obesity |
| 12/11/2008 | WO2008045556A3 Novel synergistic opioid-cannabinoid codrug for pain management |
| 12/11/2008 | WO2008045461A3 Transdermal diethylstilbestrol for treating prostate cancer |
| 12/11/2008 | WO2008044782A3 Combination drug |
| 12/11/2008 | WO2008041966A3 Broad spectrum antibacterial compounds |
| 12/11/2008 | WO2008039640A3 Enantiomeric compounds with antibacterial activity |
| 12/11/2008 | WO2008039615A3 Controlled release hydrogel formulation |
| 12/11/2008 | WO2008034041A3 Therapeutic combinations |
| 12/11/2008 | WO2008034039A3 Novel tetrahydro-isoquinolines |
| 12/11/2008 | WO2008033757A3 2-(1-oxo-1h-isoquinolin-2-yl) acetamide derivatives |
| 12/11/2008 | WO2008033643A3 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 12/11/2008 | WO2008033466A3 Compositions and methods for treatment of viral diseases |
| 12/11/2008 | WO2008028032A3 Therapeutic substituted hydantoins and related compounds |
| 12/11/2008 | WO2008027345A3 COMBINED γ-SECRETASE INHIBITOR AND PHENOTHIAZINE DERIVATIVE TREATMENT OF NEURODEGENERATIVE DISEASES |
| 12/11/2008 | WO2008021891A3 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 12/11/2008 | WO2008021283A3 Compositions and methods for increasing blood platelet levels in humans |
| 12/11/2008 | WO2008019388A3 Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome |
| 12/11/2008 | WO2008016669A3 Certain chemical entities, compositions and methods |
| 12/11/2008 | WO2008016522A3 Hiv reverse transcriptase inhibitors |
| 12/11/2008 | WO2008008494A3 Methods and compositions for treating mucosal inflammation |
| 12/11/2008 | WO2008008398A3 Oxime compounds and the use thereof |
| 12/11/2008 | WO2008008374A3 Ccr2 inhibitors and methods of use thereof |
| 12/11/2008 | WO2008005937A3 Treatment of neurodegenerative diseases through inhibiton of hsp90 |
| 12/11/2008 | WO2008005194A3 Method for the eradication of pathogens comprising generating molecular iodine in situ |
| 12/11/2008 | WO2008002905A3 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 12/11/2008 | WO2008001182A8 Tricyclic heteroaryl compounds as pde10 inhibitors |
| 12/11/2008 | WO2007146230A3 Non-nucleoside reverse transcriptase inhibitors |
| 12/11/2008 | WO2007145571A9 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 12/11/2008 | WO2007145570A9 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 12/11/2008 | WO2007145569A9 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 12/11/2008 | WO2007145568A9 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 12/11/2008 | WO2007137255A3 Bacterial thioredoxin reductase inhibitors and methods for use thereof |
| 12/11/2008 | WO2007130419A3 Histone deacetylase inhibitors for the treatment of neurodegeneration |
| 12/11/2008 | WO2007127839A3 Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
| 12/11/2008 | WO2007126457A3 Method and composition for treating and preventing tumor metastasis in vivo |
| 12/11/2008 | WO2007117409A3 Opiopathies |
| 12/11/2008 | WO2007116029A3 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor |
| 12/11/2008 | WO2007111958A3 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods |
| 12/11/2008 | WO2007110500A8 Use of canthin-6-one and its analogues in the treatment of pathologies linked to mycobacteria |
| 12/11/2008 | WO2007100657A3 Inhibitors of histone deacetylase |
| 12/11/2008 | WO2007096618A3 2-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use |
| 12/11/2008 | WO2007095161A3 Methods and compositions for treating disorders associated with increased bone turnover and osteopenia |
| 12/11/2008 | WO2007092364A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 12/11/2008 | WO2007089462A3 Piperidine and piperazine derivatives |
| 12/11/2008 | WO2007081542A3 Tetralone-based monoamine reuptake inhibitors |
| 12/11/2008 | WO2007075859A3 Systems and methods for the delivery of corticosteroids having an increased lung deposition |
| 12/11/2008 | WO2007075528A3 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 12/11/2008 | WO2007061661A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/11/2008 | WO2006073950B1 Nanoparticles for protein drug delivery |
| 12/11/2008 | WO2005046562A3 Use of sulfated hyaluronic acid |
| 12/11/2008 | WO2004105684A3 Combination therapy for proliferative disorders |
| 12/11/2008 | US20080306275 Novel heteroaryl derivative |
| 12/11/2008 | US20080306258 Cyclopropane compounds and pharmaceutical use thereof |
| 12/11/2008 | US20080306166 Compositions and Methods For Treatment of Disorders of Protein Aggregation |
| 12/11/2008 | US20080306165 Compounds for the Treatment of Metabolic Disorders |
| 12/11/2008 | US20080306164 hydroxysteroid reductase inhibitors such as 2-Methoxy-17a-oxo-17a-homoestra-1,3,5(1 O)-trines-3-ol, used for treating of estrogen-dependent diseases, selected from breast cancer, prostate cancer and endometriosis |
| 12/11/2008 | US20080306163 such as conjunctivitis via administering (+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one; phosphodiesterase inhibitors; for topical administration and for use as drops |
| 12/11/2008 | US20080306162 Treatment of Inflammatory Disorders and Pain |
| 12/11/2008 | US20080306161 Use of Axomadol for Treatment of Arthrosis Pain |
| 12/11/2008 | US20080306160 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 12/11/2008 | US20080306159 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine |
| 12/11/2008 | US20080306158 Methods to Prevent Cytotoxicity Using N-Acetyl-Cysteine |
| 12/11/2008 | US20080306157 Therapeutic intervention to MIMIC the effect of caloric restriction |
| 12/11/2008 | US20080306156 Method of using catalpic acid to treat and prevent type 2 diabetes and associated disorders |
| 12/11/2008 | US20080306155 Method for treating renal disease |
| 12/11/2008 | US20080306154 Treatment and prevention of major adverse cardiovascular events or major coronary evens by administering Omega-3 fatty acids |
| 12/11/2008 | US20080306153 Lipids and lipid assemblies comprising transfection enhancer elements |
| 12/11/2008 | US20080306152 Compositions containing prodrugs of florfenicol and methods of use |
| 12/11/2008 | US20080306151 Deuterium-enriched fenofibrate |
| 12/11/2008 | US20080306150 Compounds for the Treatment of Metabolic Disorders |
| 12/11/2008 | US20080306149 Use for a Composition Comprising Chloroprocaine Hcl, a New Composition Comprising Chloroprocaine Hcl and a Method for Its Manufacture |
| 12/11/2008 | US20080306148 Anti-cancer compositions and methods |